Home » Reports » Broker Ratings » GlaxoSmithKline plc 2.4% Potential Upside Indicated by Credit Suisse

GlaxoSmithKline plc 2.4% Potential Upside Indicated by Credit Suisse

GlaxoSmithKline plc using EPIC/TICKER code (LON:GSK) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘NEUTRAL’ today by analysts at Credit Suisse. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. Credit Suisse have set a target price of 1860 GBX on its stock. This would imply the analyst believes there is now a potential upside of 2.4% from today’s opening price of 1815.8 GBX. Over the last 30 and 90 trading days the company share price has increased 37.6 points and increased 164 points respectively. The 1 year high share price is 1850.4 GBX while the 52 week low for the stock is 1429.8 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,767.34 GBX and a 200 day moving average of 1,677.72. There are currently 1,312,137,976 shares in issue with the average daily volume traded being 8,674,783. Market capitalisation for LON:GSK is £89,852,652,264 GBP.